Morgan And Mendel Genomics, Inc.

New York, NY

UEI
JHNHD3R1TCT8
CAGE
789T7
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Subchapter S Corporation
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
369 W 120th St, New York, NY 10027, USA
Founded
2014
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract awards

Grant awards

SBA capabilities narrative

Morgan and Mendel Genomics, Inc., is a development-stage medical and biotechnology device company that has been formed to develop and commercialize genetic testing kits in the human, animal and plant genetic and genomic testing niche markets.

Quick answers

Is Morgan And Mendel Genomics, Inc. registered in SAM.gov?

Yes. Morgan And Mendel Genomics, Inc.'s SAM.gov registration is active through September 8, 2027.

What is Morgan And Mendel Genomics, Inc.'s CAGE code?

Morgan And Mendel Genomics, Inc.'s CAGE code is 789T7, and its Unique Entity ID (UEI) is JHNHD3R1TCT8.

What is Morgan And Mendel Genomics, Inc.'s most recent federal award?

Morgan And Mendel Genomics, Inc.'s most recent federal contract award is Novel, rapid and accurate blood tests for detecting hereditary cancer risk (FA864922P1061), from Air Force Research Laboratory (AFMC), on July 22, 2022.

On GovTribe

See Morgan And Mendel Genomics, Inc.'s full federal record

  • Federal contract awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors

Find teaming partners on GovTribe